华特达因连跌3天，招商基金旗下1只基金位列前十大股东

Group 1 - The core point of the news is that Huate Dain has experienced a decline in stock price over three consecutive trading days, with a cumulative drop of -0.59% [1] - Huate Dain Health Co., Ltd. is listed on the Shenzhen Stock Exchange with the stock code 000915 [1] - In the second quarter of this year, the Zhaoshang Fund's Zhaoshang Medical Health Industry Stock Fund entered the top ten shareholders of Huate Dain, marking a new investment [1] Group 2 - The Zhaoshang Medical Health Industry Stock Fund has achieved a year-to-date return of 31.18%, ranking 223 out of 979 in its category [2] - The fund's performance over various periods includes a 1-week increase of 1.28%, a 1-month increase of 5.01%, a 3-month increase of 24.50%, a 6-month increase of 25.57%, and a year-to-date increase of 31.189% [2] - The average performance of similar funds for the year is 22.009%, indicating that Zhaoshang's fund has outperformed its peers [2] Group 3 - Li Jiasun, the fund manager of Zhaoshang Medical Health Industry Stock Fund, has a Master's degree in Economics and has been involved in the pharmaceutical industry research since 2008 [3][4] - Li Jiasun has been managing the Zhaoshang Medical Health Industry Stock Fund since January 30, 2015, and has a total management experience of over 10 years [4] - The Zhaoshang Fund Management Co., Ltd. was established in December 2002, with major shareholders being China Merchants Bank and China Merchants Securities [4]